Literature DB >> 12878732

Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol.

Elisabetta Vegeto1, Silvia Belcredito, Sabrina Etteri, Serena Ghisletti, Alessia Brusadelli, Clara Meda, Andrée Krust, Sonia Dupont, Paolo Ciana, Pierre Chambon, Adriana Maggi.   

Abstract

Beyond the key role in reproductive and cognitive functions, estrogens have been shown to protect against neurodegeneration associated with acute and chronic injuries of the adult brain. Current hypotheses reconcile this activity with a direct effect of 17beta-estradiol (E2) on neurons. Here we demonstrate that brain macrophages are also involved in E2 action on the brain. Systemic administration of hormone prevents, in a time- and dose-dependent manner, the activation of microglia and the recruitment of peripheral monocytes induced by intraventricular injection of lipopolysaccharide. This effect occurs by limiting the expression of neuroinflammatory mediators, such as the matrix metalloproteinase 9 and lysosomal enzymes and complement C3 receptor, as well as by preventing morphological changes occurring in microglia during the inflammatory response. By injecting lipopolysaccharide in estrogen receptor (ER)-null mouse brains, we demonstrate that hormone action is mediated by activation of ERalpha but not of ERbeta. The specific role of ERalpha is further confirmed by comparing the effects of ERs on the matrix metalloproteinase 9 promoter activity in transient transfection assays. Finally, we report that genetic ablation of ERalpha is associated with a spontaneous reactive phenotype of microglia in specific brain regions of adult ERalpha-null mice. Altogether, these results reveal a previously undescribed function for E2 in brain and provide a mechanism for its beneficial activity on neuroinflammatory pathologies. They also underline the key role of ERalpha in brain macrophage reactivity and hint toward the usefulness of ERalpha-specific drugs in hormone replacement therapy of inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12878732      PMCID: PMC170966          DOI: 10.1073/pnas.1531957100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

Review 1.  Changes in proinflammatory cytokine activity after menopause.

Authors:  Johannes Pfeilschifter; Roland Köditz; Martin Pfohl; Helmut Schatz
Journal:  Endocr Rev       Date:  2002-02       Impact factor: 19.871

Review 2.  Effects of estrogen on the vascular wall: vasomotor function and inflammation.

Authors:  Kwang Kon Koh
Journal:  Cardiovasc Res       Date:  2002-09       Impact factor: 10.787

3.  Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain.

Authors:  L J Lawson; V H Perry; P Dri; S Gordon
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

4.  Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.

Authors:  Peter P Zandi; Michelle C Carlson; Brenda L Plassman; Kathleen A Welsh-Bohmer; Lawrence S Mayer; David C Steffens; John C S Breitner
Journal:  JAMA       Date:  2002-11-06       Impact factor: 56.272

Review 5.  Estrogen and cognitive aging in women.

Authors:  Barbara B Sherwin
Journal:  Trends Pharmacol Sci       Date:  2002-11       Impact factor: 14.819

6.  The impact of reproductive events on the course of bipolar disorder in women.

Authors:  Marlene P Freeman; Kathy Wosnitzer Smith; Scott A Freeman; Susan L McElroy; Geri E Kmetz; Ron Wright; Paul E Keck
Journal:  J Clin Psychiatry       Date:  2002-04       Impact factor: 4.384

7.  Disruption of estrogen receptor beta gene impairs spatial learning in female mice.

Authors:  Emilie F Rissman; Amy L Heck; Julie E Leonard; Margaret A Shupnik; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

Review 8.  The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease.

Authors:  Paul S Aisen
Journal:  Lancet Neurol       Date:  2002-09       Impact factor: 44.182

9.  The clinical course of multiple sclerosis during pregnancy and the puerperium.

Authors:  K Birk; C Ford; S Smeltzer; D Ryan; R Miller; R A Rudick
Journal:  Arch Neurol       Date:  1990-07

10.  In vivo imaging of transcriptionally active estrogen receptors.

Authors:  Paolo Ciana; Michele Raviscioni; Paola Mussi; Elisabetta Vegeto; Ivo Que; Malcolm G Parker; Clemens Lowik; Adriana Maggi
Journal:  Nat Med       Date:  2002-12-16       Impact factor: 53.440

View more
  129 in total

1.  17beta-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss.

Authors:  Lorelei C Taylor; Kasturi Puranam; Wendy Gilmore; Jenny P-Y Ting; Glenn K Matsushima
Journal:  Neurobiol Dis       Date:  2010-03-27       Impact factor: 5.996

Review 2.  Toll-like receptors in chronic pain.

Authors:  Lauren Nicotra; Lisa C Loram; Linda R Watkins; Mark R Hutchinson
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

3.  17β-estradiol protects the lung against acute injury: possible mediation by vasoactive intestinal polypeptide.

Authors:  Sayyed A Hamidi; Kathleen G Dickman; Hasan Berisha; Sami I Said
Journal:  Endocrinology       Date:  2011-10-18       Impact factor: 4.736

Review 4.  Gender differences in neurological disease: role of estrogens and cytokines.

Authors:  Anna Członkowska; Agnieszka Ciesielska; Grazyna Gromadzka; Iwona Kurkowska-Jastrzebska
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

Review 5.  Multiple pathways transmit neuroprotective effects of gonadal steroids.

Authors:  Damani N Bryant; Laird C Sheldahl; Lisa K Marriott; Robert A Shapiro; Daniel M Dorsa
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

Review 6.  Structure-nongenomic neuroprotection relationship of estrogens and estrogen-derived compounds.

Authors:  Laszlo Prokai; James W Simpkins
Journal:  Pharmacol Ther       Date:  2007-02-02       Impact factor: 12.310

7.  T lymphocytes do not directly mediate the protective effect of estrogen on experimental autoimmune encephalomyelitis.

Authors:  Magdalena J Polanczyk; Richard E Jones; Sandhya Subramanian; Michael Afentoulis; Cathleen Rich; Melissa Zakroczymski; Paul Cooke; Arthur A Vandenbark; Halina Offner
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  Estrogen receptor-alpha overexpression suppresses 17beta-estradiol-mediated vascular endothelial growth factor expression and activation of survival kinases.

Authors:  Shameena Bake; Lijiang Ma; Farida Sohrabji
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

9.  Neuronal estrogen receptor-alpha mediates neuroprotection by 17beta-estradiol.

Authors:  Joachim G Elzer; Sajjad Muhammad; Tim M Wintermantel; Anne Regnier-Vigouroux; Jochen Ludwig; Günther Schütz; Markus Schwaninger
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-16       Impact factor: 6.200

10.  Estrogen receptor-alpha as a drug target candidate for preventing lung inflammation.

Authors:  Elisabetta Vegeto; Salvatore Cuzzocrea; Concetta Crisafulli; Emanuela Mazzon; Angelo Sala; Andreè Krust; Adriana Maggi
Journal:  Endocrinology       Date:  2009-12-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.